Connecting the dots...Provectus Biopharmaceuticals

Caveat: I have been hilariously off-base in the past. See, for example, my August 31, 2014 blog post  Potential Catalysts . Updated ...

§   My investment thesis is intact. Up until this point FDA regulatory clarity had been lacking and therefore commercial validation was abs...